Back to today’s briefing

Story perspectives

NIH Grant Cuts Threaten Cancer Research Advancements

6/10/2025

50 7

Summary

Story summary

Harvard researchers, spearheaded by John Quackenbush, are making groundbreaking strides in gene regulation and cancer treatment, thanks to federal funding from the NIH. Yet, recent grant terminations cast a shadow over this progress, endangering vital cancer therapies and the education of emerging scientists, which could undermine the U.S.'s position in biomedical research.

1 of 1

Story summary

Harvard researchers, spearheaded by John Quackenbush, are making groundbreaking strides in gene regulation and cancer treatment, thanks to federal funding from the NIH. Yet, recent grant terminations cast a shadow over this progress, endangering vital cancer therapies and the education of emerging scientists, which could undermine the U.S.'s position in biomedical research.